EMHTF - Emerald Health Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
2.18
+0.22 (+11.22%)
At close: 3:58PM EDT
Stock chart is not supported by your current browser
Previous Close1.96
Open2.08
Bid0.00 x 0
Ask0.00 x 0
Day's Range2.04 - 2.19
52 Week Range0.91 - 7.77
Volume335,511
Avg. Volume315,535
Market Cap299.48M
Beta4.35
PE Ratio (TTM)N/A
EPS (TTM)-0.09
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire2 hours ago

    Emerald Health Therapeutics Completes Acquisition of Licensed Dealer Northern Vine Canada

    Northern Vine is a Licensed Dealer (LD) under the provisions of the Canadian Controlled Drugs and Substances Act. The dealer license allows Emerald to participate in the growing market for cannabis analytical testing, which Emerald expects to grow in conjunction with increasing cannabis production volumes in Canada.

  • GlobeNewswireyesterday

    Abattis Completes Sale of Northern Vine Interest

    Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT / OTC: ATTBF) is pleased to announce that it has completed the sale (the “Sale”) of its 35% interest in Northern Vine Canada Inc. (“Northern Vine”) to Emerald Health Therapeutics, Inc. (TSXV:EMH / OTCQX:EMHTF) (“Emerald”) in exchange for $2 million in cash and $4 million in common shares of Emerald, 50% of which are free trading and 50% of which may be sold in 30 days. The share purchase agreement governing the Disposition (the “Agreement”) also provides that, upon Northern Vine and/or Emerald earning gross revenues of $10 million from the sale of products or provision of services to customers introduced by Abattis, Emerald will issue Abattis an additional $4 million in common shares of Emerald.

  • GlobeNewswire8 days ago

    Emerald Health Expands into Analytical Testing and Import/Export -- CFN Media

    CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Emerald Health Therapeutics Inc.'s (EMH.V) (EMHTF) recent acquisition of a dealer license from Abattis Bioceuticals Corp. that enables it to compete in emerging market verticals. For example, Canopy Growth Corp.’s Tweed Inc. acquired a dealer license back in December 2016.

  • The Under-the-Radar Reason Marijuana Stocks Are Plunging
    Motley Fool12 days ago

    The Under-the-Radar Reason Marijuana Stocks Are Plunging

    These three growers provide pretty clear evidence as to why pot stocks are swooning.

  • CNW Group16 days ago

    Village Farms International's Cannabis Joint Venture Pure Sunfarms Receives Sales License from Health Canada for 1.1 Million Square Foot Greenhouse

    OTCQX: EMHTF) ("Emerald") today announced that their 50/50 joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received its cannabis sales license from Health Canada. Pure Sunfarms is now permitted to immediately begin selling product from its expanding inventory of high-quality dried cannabis, including to Emerald Health Therapeutics, under their previously announced supply agreement, as well as to address significant demand from other licensed producers. This sales license also positions Pure Sunfarms to secure supply agreements with provincial government distributors for the imminent legal adult-use marketplace.

  • GlobeNewswire16 days ago

    Emerald Health Therapeutics’ Cannabis Joint Venture Pure Sunfarms Receives Sales License from Health Canada for 1.1 Million Square Foot Greenhouse

    Emerald Health Therapeutics, Inc. (EMH.V) (EMHTF) (“Emerald”) and Village Farms International, Inc. (“Village Farms”) (VFF.TO) (VFFIF) today announced that their 50/50 joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received its cannabis sales license from Health Canada. Pure Sunfarms is now permitted to immediately begin selling product from its expanding inventory of high-quality dried cannabis, including to Emerald Health Therapeutics, under their previously announced supply agreement, as well as to address significant demand from other licensed producers. This sales license also positions Pure Sunfarms to secure supply agreements with provincial government distributors for the imminent legal adult-use marketplace.

  • GlobeNewswire22 days ago

    Emerald Health Therapeutics Signs Cannabis Supply Memorandum of Understanding with British Columbia Liquor Distribution Branch

    Emerald Health Therapeutics, Inc. (EMH.V) (EMHTF) (“Emerald”) has signed a Memorandum of Understanding ("MOU") with the British Columbia Liquor Distribution Branch ("BCLDB") to supply its high-quality cannabis products to the BCLDB to serve the adult-use market throughout the province. “Emerald has a strong relationship with the BCLDB team, and our new supply partnership will allow us to provide them with local access to our large cannabis production capacity,” said Chris Wagner, CEO at Emerald.

  • ACCESSWIRE26 days ago

    This Unknown Mining Stock Could Return Investors 600% or More

    Substantial gold and copper deposits in Ecuador are getting renewed attention as this formerly closed region sees a new government open to investment. One of the biggest gold wins of the last decade, Fruta Del Norte, was acquired for $1.2 billion and parent company's stock ran from $0.40 to $40.00. Lucky Minerals (LJ, LKMNF) is beginning exploration of a promising concession just 40km from Fruta Del Norte, and with similar geologic features.

  • How Will Cannabis Companies Fare in the Second Half of 2018?
    Market Realist27 days ago

    How Will Cannabis Companies Fare in the Second Half of 2018?

    The cannabis sector has lost some of the attention it garnered at the beginning of this year. The sector has delivered losses with some stocks losing almost half their value since the beginning of this year. Those who invested in the sector as a whole through ETFs such as the Horizons Marijuana Life Sciences ETF (HMMJ) are also left with negative returns as of July 17.

  • GlobeNewswire27 days ago

    Emerald Health Therapeutics Completes Full Acquisition of Licensed Dealer Northern Vine to Advance Product Innovation

    Emerald Health Therapeutics, Inc. (EMH.V) (EMHTF) (Emerald) has signed a definitive agreement  (“Agreement”) to acquire the remaining shares of Northern Vine Canada Inc. (Northern Vine), owned by Abattis Bioceuticals Corp. (Abattis) (CSE:ATT) (ATTBF), for $2 million in cash and $4 million in shares of Emerald stock. Northern Vine is a Licensed Dealer (LD) under the provisions of the Canadian Controlled Drugs and Substances Act. “Product innovation is a primary pillar of Emerald’s global business strategy.

  • Time to Welcome Another Marijuana Stock to the 100,000 Kilogram Club
    Motley Foollast month

    Time to Welcome Another Marijuana Stock to the 100,000 Kilogram Club

    This is the ninth pot stock that's expected to produce in excess of 100,000 kilograms of cannabis a year.

  • GlobeNewswirelast month

    Emerald Health Therapeutics Updates on its Differentiated Strategy and Progress

    Emerald Health Therapeutics, Inc. (EMH.V) (EMHTF) (Emerald) is providing an update on its differentiated strategy to excel in the growing cannabis industry. “In Emerald’s view, the most compelling opportunities and growth in the cannabis industry will arise in serving the unmet needs of individuals seeking medicinal and wellness benefits.

  • The Worst-Performing Marijuana Stocks in the Second Quarter
    Motley Foollast month

    The Worst-Performing Marijuana Stocks in the Second Quarter

    See which pot stocks took home this "doobie-ous" honor.

  • GlobeNewswire2 months ago

    Emerald Health Therapeutics Announces Amendment to Pure Sunfarms’ Cultivation License, Substantially Expanding Cannabis Production Area to 225,000 Square Feet

    Emerald Health Therapeutics, Inc. (EMH.V) (EMHTF) (“Emerald”) and Village Farms International, Inc. (“Village Farms” or the “Company”) (VFF.TO) (VFFIF) today announced that their 50/50 joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, received from Health Canada an amendment to its cultivation license for its Delta 3 greenhouse in Delta, BC. This amendment permits Pure Sunfarms to substantially expand its cannabis production to 225,000 square feet of the 1.1-million square foot Delta 3 production facility.

  • GlobeNewswire2 months ago

    Emerald Health Therapeutics Welcomes Historic Passing of Bill C-45 to Legalize Adult-Use Cannabis in Canada

    Emerald Health Therapeutics, Inc. (EMH.V) (EMHTF) (Emerald) today applauds the Canadian government’s historic passing of Bill C-45 (Cannabis Act) to end Canada’s near century-long prohibition of recreational cannabis and usher in a new era of cannabis regulation. “Today is a historic moment for Canada with the government’s approval of the Cannabis Act, which will provide a new legal framework and establish Canada as a globally recognized leader of cannabis legalization.

  • Combined, Canada's Top 8 Pot Growers Could Yield 1.8 Million Kilograms Annually by 2020
    Motley Fool2 months ago

    Combined, Canada's Top 8 Pot Growers Could Yield 1.8 Million Kilograms Annually by 2020

    With rapid capacity expansion, marijuana oversupply remains a valid concern.

  • 3 Things to Love About Emerald Health Therapeutics' Q1 Report, and 2 Reasons to Worry
    Motley Fool2 months ago

    3 Things to Love About Emerald Health Therapeutics' Q1 Report, and 2 Reasons to Worry

    Despite rapidly expanding its weed-growing capacity, this marijuana stock is at risk of being late to the party.

  • GlobeNewswire3 months ago

    Emerald Health Therapeutics Reports 1st Quarter 2018 Financial Results and Provides Corporate Update

    Emerald Health Therapeutics, Inc. (EMH.V) (EMHTF) (“Emerald” or “the Company”) has filed its financial statements and management discussion and analysis for the fiscal quarter ended March 31, 2018. “Emerald has been very productive year-to-date in executing on three key strategic pillars: production scaling, product innovation, and branding,” said Chris Wagner, CEO of Emerald Health Therapeutics. “We received our cultivation license for our Pure Sunfarms joint venture, completed our first harvest and submitted an amendment to Health Canada for Pure Sunfarms’ sales license, and started commercial production.

  • Better Marijuana Stock: Cronos Group vs. Emerald Health Therapeutics
    Motley Fool3 months ago

    Better Marijuana Stock: Cronos Group vs. Emerald Health Therapeutics

    Which stock wins in a head-to-head matchup between these two Canadian marijuana growers?

  • GlobeNewswire3 months ago

    Emerald Health Therapeutics Closes $16.8 Million Prospectus Sale

    Emerald Health Therapeutics, Inc. (EMH.V) ("Emerald" or the “Company”) has closed its prospectus sale (the “Offering”) to a single Canadian institutional accredited investor (the “Investor”) announced on May 15, 2018. Pursuant to the Offering, the Company has issued 4,000,000 units (the “Units”) at a price per Unit of $4.20 for gross proceeds of $16,800,000. Each Unit consists of one common share of the Company and one common share purchase warrant (a “Warrant”).

  • GlobeNewswire3 months ago

    Village Farms Enters Commercial-Scale Production and Outlines Ambitious 2018 Plans -- CFN Media

    CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Village Farms International Inc. (VFF.TO) (VFFIF) joint venture with Emerald Health Therapeutics Inc. (EMH.V) (EMHTF) called Pure Sunfarms. Village Farms, which has been publicly traded for more than ten years on the TSX, is already generating about CAD$200 million in annual revenue as a large-scale, low-cost greenhouse grower -- from its decades old fresh produce business. By leaning on this experience, the vertically-integrated company is now cultivating high-quality cannabis through Pure Sunfarms, which has the potential to produce up to 300,000 kilograms of dried cannabis per year if it converts all of its existing Delta, BC-based 4.8 million sq. ft. of greenhouse space to cannabis production.

  • GlobeNewswire3 months ago

    Emerald Health Therapeutics to Present at Upcoming Investor Conferences

    VICTORIA, British Columbia, May 22, 2018-- Emerald Health Therapeutics, Inc. today announced that members of its executive team will present at upcoming investor conferences.. BMO Capital Market’ s Inaugural ...

  • This Pot Stock Has Paved a Path to More Than 100,000 Kilograms of Annual Cannabis Production
    Motley Fool3 months ago

    This Pot Stock Has Paved a Path to More Than 100,000 Kilograms of Annual Cannabis Production

    Though on track to be a major weed producer, this marijuana stock is far from a lock to succeed.